Skip to main content
Top
Published in: Annals of Hematology 12/2007

01-12-2007 | Original Article

Inhibition of adrenaline and adenosine diphosphate induced platelet aggregation by Lansberg’s hognose pit viper (Porthidium lansbergii hutmanni) venom

Authors: J. C. Lopez-Johnston, N. de Bosch, H. Scannone, A. Rodríguez-Acosta

Published in: Annals of Hematology | Issue 12/2007

Login to get access

Abstract

The haemostatic components of venom from the genus Porthidium has been poorly studied, although it is known that severe manifestations occur when humans are envenomed, which include invasive oedema and disseminated ecchymosis. The effects of venom on blood platelets are commonly studied and are normally carried out with platelet-rich plasma (PRP). A series of crude venom dilutions was used to determine the effects of adenosine diphosphate (2 μM) and adrenaline (11 μM) induced platelet aggregation. Venom of Porthidium lansbergii hutmanni was fractioned by anionic exchange chromatography, and the fractions were also used to determine the 50% inhibition of adenosine diphosphate (ADP) and adrenaline-induced platelet aggregating dose (AD50). Crude venom has more effect in inhibiting adrenaline-induced aggregation (AD50 = 0.0043 μg) followed by the adenosine diphosphate (AD50 = 17 μg). Peaks I and II obtained by chromatography also inhibited adrenaline-induced platelet aggregation with an AD50 of 3.2 and 0.013 μg, respectively, and both peaks inhibited ADP-induced platelet aggregation with an AD50 of 10 μg. The main purpose of this work was to characterise the in vitro effects caused by P. lansbergii hutmanni crude venom and its fractions on the platelet aggregation mediated by adrenaline and ADP agonists.
Literature
1.
go back to reference Gaarder A, Jonsen J, Laland S, Hellem A, Owen PA (1961) Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 192:531–532PubMedCrossRef Gaarder A, Jonsen J, Laland S, Hellem A, Owen PA (1961) Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 192:531–532PubMedCrossRef
2.
go back to reference Nubile G, Di Gregorio M, Ridolfi D, D’Alonzo L, Izzi L (1987) Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations. Quad Sclavo Diagn 23:331–340PubMed Nubile G, Di Gregorio M, Ridolfi D, D’Alonzo L, Izzi L (1987) Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations. Quad Sclavo Diagn 23:331–340PubMed
3.
go back to reference Gachet C (2006) Regulation of platelet functions by p2 receptors. Annual Rev Pharmacol Toxicol 46:277–300CrossRef Gachet C (2006) Regulation of platelet functions by p2 receptors. Annual Rev Pharmacol Toxicol 46:277–300CrossRef
4.
go back to reference Scarborough RM, Rose JW, Naughton MA, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF (1993) Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem 268:1058–1065PubMed Scarborough RM, Rose JW, Naughton MA, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF (1993) Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem 268:1058–1065PubMed
5.
go back to reference Fujimura Y, Ikeda Y, Miura S, Yoshida E, Shima H, Nishida S, Suzuki M, Titani K, Taniuchi Y, Kawasaki T (1995) Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb Hemost 74:743–750 Fujimura Y, Ikeda Y, Miura S, Yoshida E, Shima H, Nishida S, Suzuki M, Titani K, Taniuchi Y, Kawasaki T (1995) Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb Hemost 74:743–750
6.
go back to reference Fuly AL, Machado OL, Alves EW, Carlini CR (1997) Mechanism of inhibitory action on platelet activation of a phospholipase A2 isolated from Lachesis muta (Bushmaster) snake venom. Thromb Hemost 78:1372–1380 Fuly AL, Machado OL, Alves EW, Carlini CR (1997) Mechanism of inhibitory action on platelet activation of a phospholipase A2 isolated from Lachesis muta (Bushmaster) snake venom. Thromb Hemost 78:1372–1380
7.
go back to reference Clissa PB, Laing GD, Theakston RD, Mota I, Taylor MJ, Moura-da-Silva AM (2001) The effect of jararhagin, a metalloproteinase from Bothrops jararaca venom, on pro-inflammatory cytokines released by murine peritoneal adherent cells. Toxicon 39:1567–1573PubMedCrossRef Clissa PB, Laing GD, Theakston RD, Mota I, Taylor MJ, Moura-da-Silva AM (2001) The effect of jararhagin, a metalloproteinase from Bothrops jararaca venom, on pro-inflammatory cytokines released by murine peritoneal adherent cells. Toxicon 39:1567–1573PubMedCrossRef
8.
go back to reference Andrews R, Berndt M (2000) Snake venom modulators of platelet adhesion receptors and their ligands. Toxicon 38:775–791PubMedCrossRef Andrews R, Berndt M (2000) Snake venom modulators of platelet adhesion receptors and their ligands. Toxicon 38:775–791PubMedCrossRef
9.
go back to reference Otero R, Gutiérrez JM, Rojas G et al (1999) A randomized blinded clinical trial of two antivenoms, prepared by caprilic acid or ammonium sulphate fraction of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms. Toxicon 37:895–908PubMedCrossRef Otero R, Gutiérrez JM, Rojas G et al (1999) A randomized blinded clinical trial of two antivenoms, prepared by caprilic acid or ammonium sulphate fraction of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms. Toxicon 37:895–908PubMedCrossRef
10.
go back to reference Huang T, Chiang H (1994) Effect on human platelet aggregation of phospholipase A2 purified from Heloderma horridum (beaded lizard) venom. Biochim Biophys acta 1211:61–68PubMed Huang T, Chiang H (1994) Effect on human platelet aggregation of phospholipase A2 purified from Heloderma horridum (beaded lizard) venom. Biochim Biophys acta 1211:61–68PubMed
11.
go back to reference Lowry OH, Rosembrough NJ, Farr AL, Randal JH (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosembrough NJ, Farr AL, Randal JH (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
12.
go back to reference Satish S, Tejaswini J, Krishnakantha TP, Gowda TV (2004) Purification of a Class B1 platelet aggregation inhibitor phospholipase A2 from Indian cobra (Naja naja) venom. Biochimie 86:203–210PubMedCrossRef Satish S, Tejaswini J, Krishnakantha TP, Gowda TV (2004) Purification of a Class B1 platelet aggregation inhibitor phospholipase A2 from Indian cobra (Naja naja) venom. Biochimie 86:203–210PubMedCrossRef
13.
go back to reference Andriao-Escarso SH, Soares AM, Fontes MRM, Fuly AM, Correa FMA, Rosa JC, Greene LJ, Giglio JR (2000) Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive Phospholipase A2 from Bothrops jararacussu snake venom. Biochem Pharmacol 64:723–732CrossRef Andriao-Escarso SH, Soares AM, Fontes MRM, Fuly AM, Correa FMA, Rosa JC, Greene LJ, Giglio JR (2000) Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive Phospholipase A2 from Bothrops jararacussu snake venom. Biochem Pharmacol 64:723–732CrossRef
14.
go back to reference Yun-Choi HS, Park KM, Pyo MK (2000) Epinephrine induced platelet aggregation in rat platelet-rich plasma. Thromb Res 100:511–518PubMedCrossRef Yun-Choi HS, Park KM, Pyo MK (2000) Epinephrine induced platelet aggregation in rat platelet-rich plasma. Thromb Res 100:511–518PubMedCrossRef
15.
go back to reference Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:27–29CrossRef Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:27–29CrossRef
16.
go back to reference Reimers H (1985) Adenine nucleotides in blood platelets. In: Longenecker GL (ed) The platelets. Physiology and pharmacology. Academic, Orlando, FL, pp 85–106 Reimers H (1985) Adenine nucleotides in blood platelets. In: Longenecker GL (ed) The platelets. Physiology and pharmacology. Academic, Orlando, FL, pp 85–106
17.
go back to reference Maffrand JP, Bernat A, Delebassee D, Defreyn G, Cazenave JP, Gordon JL (1988) ADP plays a key role in thrombogenesis in rats. Thromb Haemost 59:225–230PubMed Maffrand JP, Bernat A, Delebassee D, Defreyn G, Cazenave JP, Gordon JL (1988) ADP plays a key role in thrombogenesis in rats. Thromb Haemost 59:225–230PubMed
18.
go back to reference Gachet C, Hechler B (2005) The platelet P2 receptors in thrombosis. Sem Thromb Hemost 31:162–167CrossRef Gachet C, Hechler B (2005) The platelet P2 receptors in thrombosis. Sem Thromb Hemost 31:162–167CrossRef
19.
go back to reference Bernabei A, Gikakis N, Kowalska MA, Niewiarowski S, Edmunds LH Jr (1995) Iloprost and echistatin protect platelets during simulated extracorporeal circulation. AnnThor Surg 59:149–153 Bernabei A, Gikakis N, Kowalska MA, Niewiarowski S, Edmunds LH Jr (1995) Iloprost and echistatin protect platelets during simulated extracorporeal circulation. AnnThor Surg 59:149–153
20.
go back to reference Huang TF, Sheu JR, Teng CM (1991) A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Biochem J 277:351–357PubMed Huang TF, Sheu JR, Teng CM (1991) A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Biochem J 277:351–357PubMed
21.
go back to reference Kemparaju K, Krishnakanth T, Gowda T (1999) Purification and characterization of a platelet aggregation inhibitor acidic phospholipase A2 from Indian saw-scaled viper (Echis carinatus). Toxicon 37:1659–1671PubMedCrossRef Kemparaju K, Krishnakanth T, Gowda T (1999) Purification and characterization of a platelet aggregation inhibitor acidic phospholipase A2 from Indian saw-scaled viper (Echis carinatus). Toxicon 37:1659–1671PubMedCrossRef
22.
go back to reference Ouyang C, Huang T (1983) Potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Biochim Biophys Acta 757:332–341PubMed Ouyang C, Huang T (1983) Potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Biochim Biophys Acta 757:332–341PubMed
23.
go back to reference Ouyang C, Huang T (1986) Platelet aggregation inhibitors from Agkistrodon acutus snake venom. Toxicon 34:1099–1106CrossRef Ouyang C, Huang T (1986) Platelet aggregation inhibitors from Agkistrodon acutus snake venom. Toxicon 34:1099–1106CrossRef
24.
go back to reference Huang T, Wu Y, Ouyang C (1987) Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom. Biochim Biophys Acta 925:248–257PubMed Huang T, Wu Y, Ouyang C (1987) Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom. Biochim Biophys Acta 925:248–257PubMed
25.
go back to reference Okuda D, Morita T (2001) Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation. J Biochem (Tokyo) 130:407–415 Okuda D, Morita T (2001) Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation. J Biochem (Tokyo) 130:407–415
Metadata
Title
Inhibition of adrenaline and adenosine diphosphate induced platelet aggregation by Lansberg’s hognose pit viper (Porthidium lansbergii hutmanni) venom
Authors
J. C. Lopez-Johnston
N. de Bosch
H. Scannone
A. Rodríguez-Acosta
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 12/2007
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-007-0354-y

Other articles of this Issue 12/2007

Annals of Hematology 12/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.